Decreasing Incidence of Chronic Lung Disease Despite the Gradual Reduction of Postnatal Dexamethasone Use in Very Low Birth Weight Infants

Dexamethasone has been widely used in very low birth weight infants (VLBWI) weighing less than 1,500 g at birth for the prevention or treatment of chronic lung disease (CLD). Recently, however the use of dexamethasone is being reduced, as its association with abnormal neurodevelopmental outcome is k...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Chang Won, Hwang, Jong Hee, Shim, Jae Won, Ko, Sun Young, Lee, Eun Kyung, Kim, Sung Shin, Chang, Yun Sil, Park, Won Soon, Shin, Son Moon
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2004
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816883/
https://www.ncbi.nlm.nih.gov/pubmed/15308840
http://dx.doi.org/10.3346/jkms.2004.19.4.514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816883/
https://www.ncbi.nlm.nih.gov/pubmed/15308840
http://dx.doi.org/10.3346/jkms.2004.19.4.514

Ejemplares similares